Meyka Pro banner
Pediatrix Medical Group, Inc.

Stay Updated with the Latest Pediatrix Medical Group, Inc. MD News in Real Time

Find MD news now at Meyka AI. Stay informed with the latest Pediatrix Medical Group, Inc. stocks updates, including price news, market analysis, and expert insights.

MDNYSE
HealthcareMedical - Care Facilities
$26.22
$0.00(0.00%)
U.S. Market opens in 15h 39m
Japan Ends 45-Hour Overtime Cap in September, Allowing Up to 100 Hours Monthly
📅 in about 4 hours

Japan Ends 45-Hour Overtime Cap in September, Allowing Up to 100 Hours Monthly

Japan ends blanket 45-hour overtime guidance in September, allowing companies with special clauses to permit up to 100 hours monthly. Labor inspectors will focus on worker health protections instead.

Read more 12
Bitcoin Surges Past $71,000 as Trump Backs Crypto Clarity Act, August 21
📅 in 21 minutes

Bitcoin Surges Past $71,000 as Trump Backs Crypto Clarity Act, August 21

Bitcoin surged past $71,000 on August 20 as falling US Treasury yields and Trump’s crypto meeting sparked a $2.7 billion short squeeze. The rally marks the coin’s highest level since early June.

Read more 12
Moderna Soars 122% on Melanoma Vaccine Breakthrough, August 21
📅 39 minutes ago

Moderna Soars 122% on Melanoma Vaccine Breakthrough, August 21

Moderna stock jumps 122% after announcing its personalized mRNA melanoma vaccine met Phase 3 trial goals. The vaccine reduced cancer recurrence and spread when combined with Merck’s Keytruda.

Read more 12
SATS Slides 13.6% After Q1 Profit Growth Slows on Margin Squeeze
📅 1 hour ago

SATS Slides 13.6% After Q1 Profit Growth Slows on Margin Squeeze

SATS stock drops 13.6% to S$4.12 after Q1 earnings disappoint. Net profit rose 6% to S$75.1M but margin compression from geopolitical tensions weighs on investor sentiment.

Read more 12
Jennifer Hegseth’s Pentagon Role Sparks Controversy on August 20
📅 4 hours ago

Jennifer Hegseth’s Pentagon Role Sparks Controversy on August 20

Jennifer Hegseth, Defense Secretary Pete Hegseth’s wife, has become his most influential Pentagon adviser, attending sensitive meetings and helping shape press policies. Former Pentagon officials call her role unprecedented and concerning.

Read more 12
JD Sports Stock Plunges 10.98% as Retailer Cuts Profit Outlook on Weak Sales
📅 6 hours ago

JD Sports Stock Plunges 10.98% as Retailer Cuts Profit Outlook on Weak Sales

JD Sports stock plunged 10.98% on August 20, 2026, after the sportswear retailer lowered its full-year profit outlook following weaker second-quarter sales. Group like-for-like sales fell 3.1%, while North American sales dropped 6.8%, adding pressure to the company’s growth plans. JD Sports now expects adjusted pre-tax profit of £700 million to £800 million, below its…

Read more 12
UK Stock Market Today: FTSE 100 Falls 0.27% to 10,714.38, Eyes 10,750 Open as Oil Stays Above $91
📅 6 hours ago

UK Stock Market Today: FTSE 100 Falls 0.27% to 10,714.38, Eyes 10,750 Open as Oil Stays Above $91

The UK stock market slipped Thursday, with the FTSE 100 trading around 10,713 points, down roughly 0.3% from Wednesday’s close of 10,743.35. The decline snapped a brief rebound after Wednesday’s 0.14% gain ended a six-session losing streak. Brent crude held above $91 a barrel, adding pressure on rate-sensitive sectors. JD Sports Fashion led individual losses…

Read more 12
Hays Stock Rises 0.52% as Recruiter Cuts Dividend 65% Amid Hiring Slump
📅 6 hours ago

Hays Stock Rises 0.52% as Recruiter Cuts Dividend 65% Amid Hiring Slump

Hays stock edged up 0.52% on August 20, 2026, after the recruitment giant posted FY26 results. The company cut its total annual dividend by 65%, from 1.24 pence to 0.44 pence per share. Net fees fell as hiring activity stayed weak across Hays’ key markets. Investors focused on cost cuts and stabilizing margins rather than…

Read more 12
Moderna Soars 177% on Melanoma Vaccine Win; Merck Gains 12% on August 20
📅 8 hours ago

Moderna Soars 177% on Melanoma Vaccine Win; Merck Gains 12% on August 20

Moderna jumps 177% and Merck rises 12% after their mRNA cancer vaccine meets Phase 3 endpoints for melanoma. The combo reduced cancer recurrence and spread in over 1,100 patients.

Read more 12

MD News FAQ